Joel Naor is a physician executive with extensive experience with large, small, and early-stage biotech companies. He held chief medical officer positions of public and private companies partaking in the development of biologics, small molecules, sustained release technologies, stem cells and photodynamic therapy across multiple stages including translational and first in human programs.

Joel is enrolled in a Master of Clinical Informatics Management in Stanford University. He earned his Doctor of Medicine (M.D.) from the Technion – Israel Institute of Technology and completed training in Ophthalmology at the University of Toronto. He holds a Master of Science (MSc.) in Epidemiology from the University of Toronto and a Master of Business Administration (M.B.A.) from Simon Fraser University in Vancouver.